Heart Defects Closure Device Market

Heart Defects Closure Device Market contains market size and forecasts of Heart Defects Closure Device in global, including the following market information:
Global Heart Defects Closure Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Heart Defects Closure Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Heart Defects Closure Device companies in 2021 (%)
The global Heart Defects Closure Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Atrial Septal Defect ( ASD ) Closure Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Heart Defects Closure Device include Abbott, W.L. Gore, Medtronic Plc., Boston Scientific Corporation, St. Jude Medical, Inc., Biosense Webster, Inc., Lifetech Scientific, Starway Medical Technology, Inc. and Cardia, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Heart Defects Closure Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Heart Defects Closure Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Heart Defects Closure Device Market Segment Percentages, by Type, 2021 (%)
Atrial Septal Defect ( ASD ) Closure Device
Left Atrial Appendage ( LAA ) Closure Device
Patent Foramen Ovale ( PFO ) Closure Device
Patent Ductus Arteriosus ( PDA ) Closure Device
Ventricular Septal Defect ( VSD ) Closure Device
Others
Global Heart Defects Closure Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Heart Defects Closure Device Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Global Heart Defects Closure Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Heart Defects Closure Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Heart Defects Closure Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Heart Defects Closure Device revenues share in global market, 2021 (%)
Key companies Heart Defects Closure Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Heart Defects Closure Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
W.L. Gore
Medtronic Plc.
Boston Scientific Corporation
St. Jude Medical, Inc.
Biosense Webster, Inc.
Lifetech Scientific
Starway Medical Technology, Inc.
Cardia, Inc.
Occlutech Holding AG
SentreHEART, Inc.